Evidence map›Paper›PMID 39800411›Full record

ArticleBMJ open2025

Long-term outcome of oesophageal atresia in adolescence (TransEAsome): a national French cohort study protocol.

Mélanie Leroy, Madeleine Aumar, Marie Duhamel, Luc Dauchet, Martin Figeac, Segolene Gaillard, Regis Hankard, Julien Labreuche, Guillemette Marot, Julie Reversat and 5 more

Registry-linked trialAbstract read
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05995171 (Long Term Outcome of Easophageal Atresia), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05995171 recruitingnot on this map

Long Term Outcome of Easophageal Atresia : Transmics Profiles in Adolescence

TypeobservationalSponsorUniversity Hospital, LilleRan2023 to 2026Enrolled300ConditionsEsophageal AtresiaArmsQuestionnaire
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mélanie LeroyUniv. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000, Lille melanie.leroy@chu-lille.fr.ORCID http://orcid.org/0000-0002-6630-394X
Madeleine AumarUniv. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000, Lille.
Marie DuhamelUniv. Lille, Inserm, CHU Lille, U1192 - Protéomique Réponse Inflammatoire et Spectrométrie de Masse - PRISM, F-59000 Lille, France.
Luc DauchetCHU Lille, Department of Biostatistics, F-59000 Lille, France.
Martin FigeacUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41-UAR 2014-PLBS, F-59000 Lille, France.
Segolene GaillardHospices civils de Lyon, EPICIME-CIC 1407 de Lyon, Kids France, Inserm 1407, CHU-Lyon, 69677 Lyon, France.ORCID http://orcid.org/0000-0001-7949-2383
Regis HankardFrench Clinical Research Infrastructure Network (F-CRIN)-PEDSTART, INSERM, University of Tours, Tours, France.
Julien LabreucheCHU Lille, Department of Biostatistics, F-59000 Lille, France.
Guillemette MarotUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41-UAR 2014-PLBS, F-59000 Lille, France.
Julie ReversatAssociation Française de l'Atrésie de l'Œsophage, Maison Alfort, France.
Viviane ArmandAssociation Française de l'Atrésie de l'Œsophage, Maison Alfort, France.
Michel SalzetUniv. Lille, Inserm, CHU Lille, U1192 - Protéomique Réponse Inflammatoire et Spectrométrie de Masse - PRISM, F-59000 Lille, France.
Rony SfeirCHU Lille, Reference Center for Congenital Oesophageal Anomalies, F-59000 Lille, France.
Jimmy VandelUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41-UAR 2014-PLBS, F-59000 Lille, France.
Frédéric GottrandUniv. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000, Lille.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe METHODS AND ANALYSIS: ETHICS AND DISSEMINATION: The study, coconstructed with input from patients, parents and research-expert adolescents, has obtained approval from the ethics research committee: Comité de protection des personnes Est II. Findings will be disseminated to various target audiences, including the scientific community, research participants, the patient community, the general public, regulatory authorities and policymakers. Data will be made available in a Findable, Accessible, Interoperable, Reusable format on the France Cohortes platform on study completion. TRIAL REGISTRATION NUMBER: NCT05995171:Clinical trial.

Indexed as

Esophageal AtresiaGastroesophageal RefluxAdolescentCohort StudiesFemaleFranceHumansMalePrevalenceRegistriesResearch DesignRisk FactorsAdolescentsOesophageal diseasePaediatric gastroenterologyPatient Reported Outcome MeasuresQuality of Life

Identifiers

PMID39800411
PMCPMC11749844

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.